News
-
BIO-WHITE Beauty takes consumer gong
Monday | Nov 19 2018ENERVITE'S BIO-WHITE Beauty has been named "Anti-Aging Supplement Product of the Year" for 2019, in the world's largest consumer-voted award for product innovation.
-
Asbestos meeting
Monday | Nov 19 2018MORE than 300 professionals in asbestos across the health, medical research, environment, legal, workplace and regulatory sectors are gathered today and tomorrow in Sydney to help progress the development of national plans to reduce Australian's exposure to asbestos and asbestos-related disease.
-
Allergan sponsorship
Monday | Nov 19 2018OPHTHALMOLOGY specialist firm Allergan Australia has announced a $300,000 platinum sponsorship deal for Glaucoma Australia, with the three year partnership focusing on early detection and treatment adherence to prevent irreversible blindness.
-
GP imprisoned over pharmacist attack
Monday | Nov 19 2018THE doctor who tried to kill a pharmacist in Port Lincoln, South Australia (PD 08 Nov) has been sentenced to 15 years in prison with a 10 year non-parole period.
-
Novartis takes out SA award
Monday | Nov 19 2018NOVARTIS Australia has taken out the inaugural SA Health Partnership Award, with the accolade celebrating "best practice procurement improving health services for South Australians".
-
Stroke risky AF
Monday | Nov 19 2018THE AF (Atrial Fibrillation) Association has launched Global AF Aware Week 2018, with the theme of "Detect, Protect, Correct".
-
Opt in, out any time
Monday | Nov 19 2018HEALTH Minister Greg Hunt has reminded the public that the opportunity to opt out or opt back into the My Health Record system applies at any time in a person's life.
-
Rare Diseases plan
Monday | Nov 19 2018THE Federal Government has launched Australia's first National Rare Diseases Framework and Action Plan.
-
New diarrhoea drug
Monday | Nov 19 2018THE US Food and Drug Administration has approved Aemcolo (rifamycin), a newly released antibacterial drug indicated for the treatment of travellers' diarrhoea.
-
Pfizer price rises
Monday | Nov 19 2018PFIZER has announced it will be raising the price of 41 drugs from early 2019, with a US announcement saying about 10% of its portfolio is affected.
